User profiles for John Muscedere
 | John MuscedereQueen's University Verified email at kingstonhsc.ca Cited by 18072 |
Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
[HTML][HTML] A randomized trial of glutamine and antioxidants in critically ill patients
Background Critically ill patients have considerable oxidative stress. Glutamine and antioxidant
supplementation may offer therapeutic benefit, although current data are conflicting. …
supplementation may offer therapeutic benefit, although current data are conflicting. …
Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia
…, D Heyland, M Jacka, L Hand, J Muscedere… - Annals of Internal …, 2004 - acpjournals.org
Background: Ventilator-associated pneumonia (VAP) is an important patient safety issue in
critically ill patients. Purpose: To develop an evidence-based guideline for the prevention of …
critically ill patients. Purpose: To develop an evidence-based guideline for the prevention of …
[HTML][HTML] The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis
J Muscedere, B Waters, A Varambally… - Intensive care …, 2017 - Springer
Purpose Functional status and chronic health status are important baseline characteristics
of critically ill patients. The assessment of frailty on admission to the intensive care unit (ICU) …
of critically ill patients. The assessment of frailty on admission to the intensive care unit (ICU) …
Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases …
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
[HTML][HTML] Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care …
SP Keenan, T Sinuff, KEA Burns, J Muscedere… - Cmaj, 2011 - Can Med Assoc
© 2011 Canadian Medical Association or its licensors CMAJ, February 22, 2011, 183 (3)
E195 backgrounds in clinical and/or nonclinical expertise: 15 were experts in critical care …
E195 backgrounds in clinical and/or nonclinical expertise: 15 were experts in critical care …
Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention
J Muscedere, P Dodek, S Keenan, R Fowler… - Journal of critical …, 2008 - Elsevier
BACKGROUND: Ventilator-associated pneumonia (VAP) is an important cause of morbidity
and mortality in ventilated critically ill patients. PURPOSE: To develop evidence-based …
and mortality in ventilated critically ill patients. PURPOSE: To develop evidence-based …
Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis
J Muscedere, O Rewa, K Mckechnie, X Jiang… - Critical care …, 2011 - journals.lww.com
Background and Purpose: Aspiration of secretions containing bacterial pathogens into the
lower respiratory tract is the main cause of ventilator-associated pneumonia. Endotracheal …
lower respiratory tract is the main cause of ventilator-associated pneumonia. Endotracheal …
Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial
Importance Growing interest in microbial dysbiosis during critical illness has raised
questions about the therapeutic potential of microbiome modification with probiotics. Prior …
questions about the therapeutic potential of microbiome modification with probiotics. Prior …
Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia
JG Muscedere, A Day… - Clinical infectious …, 2010 - academic.oup.com
Appropriate end points are crucial for the successful interpretation of clinical trials. Choosing
end points for therapeutic trials of ventilator-associated pneumonia (VAP) and hospital-…
end points for therapeutic trials of ventilator-associated pneumonia (VAP) and hospital-…